MATRIX PHARMACEUTICALS ApS: Financial statements 2018
CVR: 29625867
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
MATRIX PHARMACEUTICALS ApS (CVR 29625867) has filed annual accounts for 2018. In 2018, the company reported revenue of EUR -55,731 and a net result of EUR -637,810 compared with DKK -368,860 the year before. Equity in the 2018 report amounted to EUR -1,875,332.
- Revenue
- EUR -55,731
- Profit/Loss
- EUR -637,810
- Equity
- EUR -1,875,332
- Total Assets
- EUR 1,941,926
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | -56 t. EUR | - | -638 t. EUR | -1.9 mio. EUR | - |
| 2017 | - | 267 t. | -369 t. | -1.2 mio. | - |
| 2016 | - | -40 t. | -338 t. | 459 t. | - |
| 2015 | - | 450 t. | 211 t. | 797 t. | - |
| 2014 | - | 929 t. | 754 t. | 587 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
MATRIX PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK 266,980, and the net result was DKK -368,860.
About MATRIX PHARMACEUTICALS ApS
MATRIX PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karsten Høilund Skafte. The board consists of Karsten Høilund Skafte. The company is owned by Karsten Høilund Skafte and KHS HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 1,090,380 and a net result of DKK 589,123 compared with DKK 440,028 the year before. Equity in the 2025 report amounted to DKK 589,123.